GE Healthcare Acquisition of SeqWright, Expanding Capabilities in Fast Growing Molecular Diagnostic Segment
4/4/2012 10:02:27 AM
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE: GE) announced today that it has acquired SeqWright, Inc., a provider of nucleic acid sequencing and other genomic services. The acquisition adds complementary genomics capabilities to Clarient, a unit of GE Healthcare and a leader in the fast-growing molecular diagnostics sector. The deal also provides a platform for Clarient to expand its clinical diagnostic offerings to include next generation sequencing. Financial terms of the acquisition were not disclosed.